Metro Healthcare Berhad (KLSE:METRO)
Malaysia · Delayed Price · Currency is MYR 0.2000
-0.0100 (-4.76%)
At close: Sep 2, 2026
Metro Healthcare Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 201 | 215 | 181 | 389 | 419 | 333 | |
Market Cap Growth | -6.82% | 19.05% | -53.44% | -7.35% | 25.93% | 52.45% |
Enterprise Value | 168 | 174 | 185 | 394 | 419 | 329 |
Last Close Price | 0.20 | 0.22 | 0.21 | 0.45 | 0.48 | 0.38 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.27 | 36.74 | 39.68 | 62.19 | 83.61 | 35.29 |
Forward PE | - | 41.82 | 23.16 | - | - | - |
PS Ratio | 3.93 | 4.27 | 3.72 | 8.70 | 10.41 | 7.88 |
PB Ratio | 2.67 | 2.87 | 2.39 | 10.40 | 11.90 | 9.70 |
P/TBV Ratio | 2.68 | 2.87 | 2.39 | 10.40 | 11.90 | 9.70 |
P/FCF Ratio | 28.42 | 28.37 | 32.44 | 52.62 | 89.75 | 46.22 |
P/OCF Ratio | 19.03 | 23.74 | 18.10 | 35.53 | 45.33 | 27.51 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.28 | 3.46 | 3.80 | 8.82 | 10.41 | 7.78 |
EV/EBITDA Ratio | 12.51 | 16.80 | 17.40 | 33.77 | 42.04 | 23.51 |
EV/EBIT Ratio | 21.32 | 25.10 | 24.97 | 44.42 | 57.46 | 27.45 |
EV/FCF Ratio | 23.77 | 22.94 | 33.15 | 53.35 | 89.73 | 45.64 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.24 | 0.19 | 0.21 | 0.48 | 0.29 | 0.32 |
Debt / EBITDA Ratio | 1.32 | 1.13 | 1.25 | 1.28 | 0.72 | 0.63 |
Debt / FCF Ratio | 2.51 | 1.88 | 2.87 | 2.41 | 2.18 | 1.55 |
Net Debt / Equity Ratio | -0.44 | -0.54 | -0.53 | -0.03 | -0.14 | -0.14 |
Net Debt / EBITDA Ratio | -2.93 | -3.91 | -3.76 | -0.10 | -0.49 | -0.35 |
Net Debt / FCF Ratio | -4.65 | -5.34 | -7.17 | -0.16 | -1.04 | -0.68 |
Asset Turnover | 0.53 | 0.54 | 0.62 | 0.81 | 0.79 | 0.96 |
Inventory Turnover | 12.09 | 11.99 | 13.43 | 15.18 | 15.93 | 18.38 |
Quick Ratio | 8.25 | 11.31 | 10.04 | 3.53 | 3.01 | 3.34 |
Current Ratio | 8.62 | 11.89 | 10.47 | 3.91 | 3.33 | 3.79 |
Return on Equity (ROE) | 9.24% | 7.78% | 8.07% | 17.21% | 14.42% | 33.10% |
Return on Assets (ROA) | 5.13% | 4.60% | 5.94% | 9.98% | 8.98% | 16.98% |
Return on Invested Capital (ROIC) | 14.07% | 14.18% | 13.10% | 19.48% | 16.58% | 33.33% |
Return on Capital Employed (ROCE) | 8.60% | 7.90% | 8.20% | 16.40% | 16.00% | 26.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.42% | 2.72% | 2.52% | 1.61% | 1.20% | 2.83% |
FCF Yield | 3.52% | 3.52% | 3.08% | 1.90% | 1.11% | 2.16% |
Dividend Yield | 2.50% | 2.99% | 2.56% | 1.19% | 1.05% | 0.43% |
Payout Ratio | 71.38% | 108.55% | 97.39% | 69.10% | 81.15% | 14.16% |
Buyback Yield / Dilution | 7.41% | - | -19.05% | 0.55% | -0.55% | -1.82% |
Total Shareholder Return | 9.91% | 2.99% | -16.48% | 1.73% | 0.50% | -1.40% |